Studies have demonstrated high sensitivity and specificity, allowing for the avoidance of BIPSS in up to 47% of patients with ACTH-dependent Cushing’s syndrome (86). This evidence concerns the gene POMC and Cushing syndrome due to macronodular adrenal hyperplasia.